东亚药业(605177)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

605177 东亚药业

已收盘 09-18 15:00:00

{"stockData":{"symbol":"605177","market":"SH","secType":"STK","nameCN":"东亚药业","latestPrice":16.25,"timestamp":1726642800000,"preClose":16.47,"halted":0,"volume":699410,"delay":0,"floatShares":114999999,"shares":114999999,"eps":0.8637,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.22,"latestTime":"09-18 15:00:00","open":16.47,"high":16.53,"low":16.08,"amount":11368400,"amplitude":0.0273,"askPrice":16.25,"askSize":201,"bidPrice":16.22,"bidSize":89,"shortable":0,"etf":0,"ttmEps":0.8637,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1726709400000},"adr":0,"adjPreClose":16.47,"symbolType":"stock","openAndCloseTimeList":[[1726623000000,1726630200000],[1726635600000,1726642800000]],"highLimit":18.12,"lowLimit":14.82,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":114753335,"pbRate":0.98,"roa":"--","roe":"1.61%","epsLYR":1.07,"committee":-0.348371,"marketValue":1865000000,"floatMarketCap":1865000000,"peRate":18.814404,"changeRate":-0.0134,"turnoverRate":0.0061,"status":1},"requestUrl":"/m/hq/s/605177/wiki","defaultTab":"wiki","newsList":[{"id":"2466986352","title":"【机构调研记录】永赢基金调研东亚药业、航宇科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2466986352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466986352?lang=zh_cn&edition=full","pubTime":"2024-09-12 08:02","pubTimestamp":1726099356,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及9月11日披露的机构调研信息，永赢基金近期对2家上市公司进行了调研，相关名单如下：1）东亚药业 个股亮点：东亚转债于2023-08-02上市；公司在上海张江和杭州下沙分别设立了原料药、制剂、合成生物学医药研发平台;正在浙江三新建大健康产业综合性生产基地。旗下最近一年表现最佳的公募基金产品为永赢股息优选A，最新单位净值为1.29，近一年增长20.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091200006123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239","688239","BK0279"],"gpt_icon":0},{"id":"2466111402","title":"东亚药业：9月10日接受机构调研，中信建投、华西证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2466111402","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466111402?lang=zh_cn&edition=full","pubTime":"2024-09-11 19:06","pubTimestamp":1726052788,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年9月11日东亚药业发布公告称公司于2024年9月10日接受机构调研，中信建投、华西证券、永赢基金参与。国内已在CDE报批中，目前在等待取得生产批件的阶段。答：公司2023年推出的购计划，截至2024年7月31日已实施完毕，购的股份拟用于实施员工持股计划或股权激励。东亚药业主营业务：化学原料药、医药中间体的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091100033679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0276","605177","002926","601066"],"gpt_icon":0},{"id":"2466289422","title":"东亚药业新提交2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2466289422","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466289422?lang=zh_cn&edition=full","pubTime":"2024-09-11 14:05","pubTimestamp":1726034724,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日浙江东亚药业股份有限公司新提交2件商标注册申请。商标申请详情如下：今年以来浙江东亚药业股份有限公司新申请注册商标7件，截止目前公司共持有注册商标68件，另有7件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091100019355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"gpt_icon":0},{"id":"2466150903","title":"东亚药业：9月9日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2466150903","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466150903?lang=zh_cn&edition=full","pubTime":"2024-09-09 18:25","pubTimestamp":1725877519,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年9月9日东亚药业发布公告称公司于2024年9月9日召开业绩说明会。截止2024年7月31日，公司本次购已实施完毕。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090900025722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"gpt_icon":0},{"id":"2464800818","title":"东亚药业：\n截至2024年8月30日，公司股东人数为10684户","url":"https://stock-news.laohu8.com/highlight/detail?id=2464800818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464800818?lang=zh_cn&edition=full","pubTime":"2024-09-02 19:01","pubTimestamp":1725274871,"startTime":"0","endTime":"0","summary":"证券之星消息，东亚药业(605177)09月02日在投资者关系平台上答复投资者关心的问题。投资者：请问，截至2024年8月30日，公司的股东数是多少？谢谢东亚药业董秘：尊敬的投资者，您好！截至2024年8月30日，公司股东人数为10684户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090200026496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"gpt_icon":0},{"id":"2463203311","title":"东亚药业（605177）8月30日主力资金净卖出45.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2463203311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463203311?lang=zh_cn&edition=full","pubTime":"2024-08-30 15:14","pubTimestamp":1725002050,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月30日收盘，东亚药业报收于18.44元，下跌1.13%，换手率1.99%，成交量2.29万手，成交额4214.65万元。8月30日的资金流向数据方面，主力资金净流出45.48万元，占总成交额1.08%，游资资金净流入248.36万元，占总成交额5.89%，散户资金净流出202.87万元，占总成交额4.81%。东亚药业主营业务：化学原料药、医药中间体的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083000021573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"gpt_icon":0},{"id":"2463281613","title":"图解东亚药业中报：第二季度单季净利润同比减73.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463281613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463281613?lang=zh_cn&edition=full","pubTime":"2024-08-29 17:31","pubTimestamp":1724923898,"startTime":"0","endTime":"0","summary":"证券之星消息，东亚药业2024年中报显示，公司主营收入6.48亿元，同比下降3.85%；归母净利润3247.3万元，同比下降40.54%；扣非净利润2693.32万元，同比下降47.15%；其中2024年第二季度，公司单季度主营收入2.96亿元，同比下降2.9%；单季度归母净利润843.38万元，同比下降73.13%；单季度扣非净利润655.66万元，同比下降76.93%；负债率39.68%，投资收益287.04万元，财务费用-208.12万元，毛利率25.81%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900033556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177"],"gpt_icon":0},{"id":"2463958288","title":"东亚药业最新公告：上半年净利润同比下降40.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463958288","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463958288?lang=zh_cn&edition=full","pubTime":"2024-08-29 16:31","pubTimestamp":1724920276,"startTime":"0","endTime":"0","summary":"东亚药业发布2024年半年度报告，公司上半年实现营业收入6.48亿元，同比下降3.85%；净利润3247.3万元，同比下降40.54%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900028455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177"],"gpt_icon":0},{"id":"2463042344","title":"东亚药业(605177.SH)发布上半年业绩，净利润3247.3万元，下降40.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463042344","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463042344?lang=zh_cn&edition=full","pubTime":"2024-08-29 15:45","pubTimestamp":1724917527,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东亚药业(605177.SH)发布2024年半年度报告，报告期内，公司实现营业收入6.48亿元，同比下降3.85%。实现归属于上市公司股东的净利润3247.3万元，同比下降40.54%。实现归属于上市公司股东的扣除非经常性损益的净利润2693.32万元，同比下降47.15%。基本每股收益0.29元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1174553.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["605177"],"gpt_icon":0},{"id":"2463402876","title":"东亚药业：2024年半年度净利润约3247万元，同比下降40.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463402876","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463402876?lang=zh_cn&edition=full","pubTime":"2024-08-29 15:44","pubTimestamp":1724917473,"startTime":"0","endTime":"0","summary":"每经AI快讯，东亚药业（SH 605177，收盘价：18.65元）8月29日晚间发布半年度业绩报告称，2024年上半年营业收入约6.48亿元，同比减少3.85%；归属于上市公司股东的净利润约3247万元，同比减少40.54%；基本每股收益0.29元，同比减少39.58%。截至发稿，东亚药业市值为21亿元。道达号（daoda1997）“个股趋势”提醒：1. 近30日内无机构对东亚药业进行调研。每经头条（nbdtoutiao）——3年收益-24.38%，这只“目标日期2035”的养老目标基金清盘！网友调侃：人没退休，养老基金先清盘了(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408291546069f649cbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408291546069f649cbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605177"],"gpt_icon":0},{"id":"2462321944","title":"东亚药业：\n截止2024年8月20日，公司股东人数为9509名","url":"https://stock-news.laohu8.com/highlight/detail?id=2462321944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462321944?lang=zh_cn&edition=full","pubTime":"2024-08-28 18:01","pubTimestamp":1724839284,"startTime":"0","endTime":"0","summary":"证券之星消息，东亚药业(605177)08月28日在投资者关系平台上答复投资者关心的问题。投资者：请问现在股东数多少？东亚药业董秘：尊敬的投资者：您好！截止2024年8月20日，公司股东人数为9509名。感谢您对公司的关注！投资者：请问最新股东人数是多少？东亚药业董秘：尊敬的投资者：您好！截止2024年8月20日，公司股东人数为9509名。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800035001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"gpt_icon":0},{"id":"2462906892","title":"东亚药业大幅上涨 宣布投资1亿元研发创新药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2462906892","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462906892?lang=zh_cn&edition=full","pubTime":"2024-08-27 09:53","pubTimestamp":1724723612,"startTime":"0","endTime":"0","summary":"08月27日，东亚药业股价大幅上涨，截至09点53分，东亚药业上涨5.02%，报19.24元/股，成交2302万元，换手率1.07%，振幅5.51%。消息解读东亚药业近期发布了2022年第一季度财报。此外，东亚药业还宣布了一项新的投资计划，计划投资1亿元用于研发创新药物。资金动向截止发稿，东亚药业获得主力净流入107万元，其中超大单流入56万元，大单流入51万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240827095449ab5fed3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240827095449ab5fed3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","605177","BK0239"],"gpt_icon":0},{"id":"2462743959","title":"东亚药业（605177）8月26日主力资金净卖出319.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462743959","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462743959?lang=zh_cn&edition=full","pubTime":"2024-08-26 15:16","pubTimestamp":1724656588,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月26日收盘，东亚药业报收于18.32元，下跌3.78%，换手率2.61%，成交量3.0万手，成交额5467.54万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：东亚药业2024年一季报显示，公司主营收入3.53亿元，同比下降4.63%；归母净利润2403.92万元，同比上升3.53%；扣非净利润2037.66万元，同比下降9.58%；负债率40.58%，投资收益189.83万元，财务费用-116.6万元，毛利率25.4%。东亚药业主营业务：化学原料药、医药中间体的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082600013318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"gpt_icon":0},{"id":"2462981097","title":"东亚药业大跌5.09% 创6月新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2462981097","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462981097?lang=zh_cn&edition=full","pubTime":"2024-08-26 09:30","pubTimestamp":1724635801,"startTime":"0","endTime":"0","summary":"08月26日，东亚药业股价大幅下跌，截至09点30分，东亚药业下跌5.09%，报18.07元/股，创近6月新低，成交134万元，换手率0.06%，振幅0.26%。资金动向截止发稿，东亚药业获得主力净流出19万元。主营业务及业绩东亚药业公司主营业务为化学原料药、医药中间体的研发、生产和销售。最新财报显示，今年一季报，东亚药业实现营业收入3.53亿元，同比减少4.63%，净利润为2,403.92万元，同比增长3.53%，基本每股收益为0.21元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240826093112ab5fa487&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240826093112ab5fa487&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605177","BK0239"],"gpt_icon":0},{"id":"2461053300","title":"东亚药业大跌5.01% 主力资金净流出804万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461053300","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461053300?lang=zh_cn&edition=full","pubTime":"2024-08-23 09:50","pubTimestamp":1724377821,"startTime":"0","endTime":"0","summary":"08月23日，东亚药业股价大幅下跌，截至09点50分，东亚药业下跌5.01%，报19.92元/股，失守20元整数关口，成交4109万元，换手率1.77%，振幅3.62%。资金动向截止发稿，东亚药业获得主力净流出804万元，其中超大单流出406万元，大单流出396万元。主营业务及业绩东亚药业公司主营业务为化学原料药、医药中间体的研发、生产和销售。最新财报显示，今年一季报，东亚药业实现营业收入3.53亿元，同比减少4.63%，净利润为2,403.92万元，同比增长3.53%，基本每股收益为0.21元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823095033ab5f3b10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823095033ab5f3b10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605177"],"gpt_icon":0},{"id":"2461738791","title":"东亚药业创1月新高 上海生物医药前沿产业创新中心与赛多利斯集团签订战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2461738791","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461738791?lang=zh_cn&edition=full","pubTime":"2024-08-22 09:32","pubTimestamp":1724290356,"startTime":"0","endTime":"0","summary":"消息解读8月20日，上海生物医药前沿产业创新中心与赛多利斯集团签订战略合作协议，标志着双方在生物医药领域的深度合作迈入新阶段。资金动向截止发稿，东亚药业获得主力净流出10万元，其中超大单流出209万元，大单流入199万元。此外，东亚药业08月21日上榜龙虎榜。最新财报显示，今年一季报，东亚药业实现营业收入3.53亿元，同比减少4.63%，净利润为2,403.92万元，同比增长3.53%，基本每股收益为0.21元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822093305ab5ef4dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822093305ab5ef4dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","161726","399441","605177"],"gpt_icon":0},{"id":"2461812686","title":"8月21日东亚药业（605177）龙虎榜数据：机构净卖出711.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461812686","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461812686?lang=zh_cn&edition=full","pubTime":"2024-08-21 17:13","pubTimestamp":1724231604,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2024年8月21日公布的交易公开信息显示，东亚药业因有价格涨跌幅限制的日收盘价格涨幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2024年8月21日收盘，东亚药业报收于21.18元，上涨10.03%，涨停，换手率3.37%，成交量3.87万手，成交额7977.99万元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出711.39万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082100030903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"gpt_icon":0},{"id":"2461814147","title":"龙虎榜|东亚药业上涨10.03%，中泰证券常州惠国路席位买入595.79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461814147","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461814147?lang=zh_cn&edition=full","pubTime":"2024-08-21 17:00","pubTimestamp":1724230829,"startTime":"0","endTime":"0","summary":"8月21日，东亚药业上涨10.03%，龙虎榜数据显示，当日上榜营业部全天成交3532.81万元，占当日总成交金额比例为44.00%。其中，买入金额为1770.15万元，卖出金额为1762.66万元，合计净买入7.50万元。此外中泰证券常州惠国路、高盛（中国）证券上海浦东新区世纪大道营业部分别买入595.79万元、317.04万元；中国银河证券上海浦东新区源深路、中国银河证券台州黄岩委羽街营业部分别卖出417.38万元、246.96万元；值得注意的是，这也是东亚药业在30日内第1次上榜龙虎榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408211700439f417787&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408211700439f417787&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0276","605177","600918","BK0239"],"gpt_icon":0},{"id":"2461981805","title":"8月21日东亚药业涨停分析：化学原料药，医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2461981805","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461981805?lang=zh_cn&edition=full","pubTime":"2024-08-21 15:32","pubTimestamp":1724225558,"startTime":"0","endTime":"0","summary":"证券之星消息，东亚药业8月21日涨停收盘，收盘价21.18元。该股于13点30分涨停，未打开涨停，截止收盘封单资金为2908.23万元，占其流通市值1.2%。8月21日的资金流向数据方面，主力资金净流入974.89万元，占总成交额12.22%，游资资金净流出121.2万元，占总成交额1.52%，散户资金净流出853.69万元，占总成交额10.7%。近5日资金流向一览见下表：该股为化学原料药，医药概念热股。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082100022534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK1574","159938","BK1161","BK1515","09939","BK0239"],"gpt_icon":0},{"id":"2461901708","title":"东亚药业（605177）8月21日主力资金净买入974.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461901708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461901708?lang=zh_cn&edition=full","pubTime":"2024-08-21 15:11","pubTimestamp":1724224261,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月21日收盘，东亚药业报收于21.18元，上涨10.03%，涨停，换手率3.37%，成交量3.87万手，成交额7977.99万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：东亚药业2024年一季报显示，公司主营收入3.53亿元，同比下降4.63%；归母净利润2403.92万元，同比上升3.53%；扣非净利润2037.66万元，同比下降9.58%；负债率40.58%，投资收益189.83万元，财务费用-116.6万元，毛利率25.4%。东亚药业主营业务：化学原料药、医药中间体的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082100020886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-11-25","address":"浙江省台州市三门县浦坝港镇沿海工业城","stockEarnings":[{"period":"1week","weight":-0.0441},{"period":"1month","weight":-0.1665},{"period":"3month","weight":-0.2733},{"period":"6month","weight":-0.2075},{"period":"1year","weight":-0.4208},{"period":"ytd","weight":-0.3685}],"companyName":"浙江东亚药业股份有限公司","boardCode":"AI0027","perCapita":"10740股","boardName":"医药制造业","registeredCapital":"11475万元","compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0514},{"period":"3month","weight":-0.1083},{"period":"6month","weight":-0.1148},{"period":"1year","weight":-0.1351},{"period":"ytd","weight":-0.091}],"survey":"　　浙江东亚药业股份有限公司的主营业务是从事化学原料药、医药中间体的研发、生产和销售；公司的主要产品是抗细菌药物、抗胆碱和合成解痉药、皮肤用抗真菌药、其他产品，产品主要涵盖抗细菌类药物（β-内酰胺类和喹诺酮类）、抗胆碱和合成解痉药物（马来酸曲美布汀）、皮肤用抗真菌药物等多个用药领域。公司累计获得授权专利36项，其中发明专利31项，是浙江省专利示范企业。公司多次承担省级重大科技专项、国家火炬计划项目、省重大国际科技专项、省重点高新技术产品开发项目等，多次获得浙江省和台州市科技进步奖等。","serverTime":1726669177217,"listedPrice":31.13,"stockholders":"10684人(较上一季度增加12.36%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东亚药业(605177)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东亚药业(605177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东亚药业,605177,东亚药业股票,东亚药业股票老虎,东亚药业股票老虎国际,东亚药业行情,东亚药业股票行情,东亚药业股价,东亚药业股市,东亚药业股票价格,东亚药业股票交易,东亚药业股票购买,东亚药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东亚药业(605177)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东亚药业(605177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}